EDGAR Filing Documents for 0000898432-07-001008

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

SEC Accession No. 0000898432-07-001008

Filing Date

2007-11-30

Accepted

2007-11-29 18:40:08

Documents

Group Members

BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq	Description	Document	Type	Size
1		bvfviacell13ga.htm	SC 13G/A	124001
	Complete submission text file	0000898432-07-001008.txt		126097

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611

Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500

BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142

Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-914-3400

VIACELL INC (Subject) CIK: 0001114529 (see all company filings)

IRS No.: 043244816 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81150 | Film No.: 071276009
SIC: 8731 Services-Commercial Physical & Biological Research